Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19

BACKGROUND: Prior studies of therapeutic-dose anticoagulation in patients with COVID-19 have reported conflicting results. OBJECTIVES: We sought to determine the safety and effectiveness of therapeutic-dose anticoagulation in noncritically ill patients with COVID-19. METHODS: Patients hospitalized w...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Gregg W., Farkouh, Michael E., Lala, Anuradha, Tinuoye, Elizabeth, Dressler, Ovidiu, Moreno, Pedro R., Palacios, Igor F., Goodman, Shaun G., Esper, Rodrigo B., Abizaid, Alexandre, Varade, Deepak, Betancur, Juan F., Ricalde, Alejandro, Payro, Gerardo, Castellano, José María, Hung, Ivan F.N., Nadkarni, Girish N., Giustino, Gennaro, Godoy, Lucas C., Feinman, Jason, Camaj, Anton, Bienstock, Solomon W., Furtado, Remo H.M., Granada, Carlos, Bustamante, Jessica, Peyra, Carlos, Contreras, Johanna, Owen, Ruth, Bhatt, Deepak L., Pocock, Stuart J., Fuster, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987252/
https://www.ncbi.nlm.nih.gov/pubmed/36889611
http://dx.doi.org/10.1016/j.jacc.2023.02.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987252/
https://www.ncbi.nlm.nih.gov/pubmed/36889611
http://dx.doi.org/10.1016/j.jacc.2023.02.041

Ejemplares similares